tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
TipRanksTop Financial ExpertsInsidersDavid Meeker

David Meeker Insider Profile

4 Followers
David Meeker, Director at Savient Pharmaceuticals, holds 12.64K shares in Savient Pharmaceuticals (Ticker: SVNTQ), holds 2.30K shares in MyoKardia (Ticker: MYOK), holds 352.49K shares in Trevi Therapeutics (Ticker: TRVI).
See the Hottest Stocks Based on Insider Trading >
tipranks
David Meeker

David Meeker
Savient Pharmaceuticals (SVNTQ)
Director

Ranked #89,061 out of 100,202 Corporate Insiders

Profitable Transactions

0%
0 out of 3 Profitable Transactions

Average Return

-49.80%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark
How are Insiders Ranked?

Insider Holdings

$11M
87.28%
12.72%
A breakdown of David Meeker's holdings
See the Top Stocks by Insiders

Insider Roles

Rhythm Pharmaceuticals
(RYTM)
President & CEO, Director
Trevi Therapeutics
(TRVI)
Director
Roles that David Meeker holds in companies
See the Top Corporate Insiders

Most Profitable Insider Trade

Stock:
Trevi Therapeutics
(TRVI)
Rating:Informative Sell
Date:Aug 29, 2024 - Today
Return:-39.10%
The most profitable trade made by David Meeker
See the Latest Stocks Traded by Insiders

David Meeker's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
SVNTQ
Savient Pharmaceuticals
Jan 09, 2013
―
Uninformative Buy
―
―
MYOK
MyoKardia
―
―
―
$517.29K
RYTM
Rhythm Pharmaceuticals
Mar 19, 2024
President & CEO, Director
Uninformative Sell
1.78M
$9.80M
TRVI
Trevi Therapeutics
Aug 29, 2024
Director
Uninformative Buy
6.51K
$1.43M
List of latest transactions for each holding click on a transaction to see David Meeker's performance on stock
See All Insider Trading from Today

You May Also Like

Meet our Smart Portfolio. See what top analysts say about your stocks.Get a breakdown of the different strategies based on detected insider trading activity.Find the best performing Analyst in each sector. Follow them so you never miss a recommendation.

David Meeker insider profile FAQ

What is the percentage of profitable transactions made by David Meeker?
The percentage of profitable transactions made by David Meeker is 0%.
    What is the average return per transaction made by David Meeker?
    The average return per transaction made by David Meeker is -49.80%.
      What stocks does David Meeker hold?
      David Meeker holds: SVNTQ, MYOK, RYTM, TRVI stocks.
        What was David Meeker’s latest transaction?
        David Meeker latest transaction was an Uninformative Buy of ―.
          What was David Meeker's most profitable transaction?
          David Meeker’s most profitable transaction was an Informative Sell of TRVI stock on August 29, 2024. The return on the trade was -39.10%.
            What is David Meeker's role in Savient Pharmaceuticals?
            David Meeker's role in Savient Pharmaceuticals is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.